Sun.Mar 31, 2024

article thumbnail

AliveCor Isn’t Backing Down from Apple, Its ‘Bully’

MedCity News

AliveCor CEO Priya Abani argues that Apple has made a habit of taking intellectual property from smaller medical device firms in order to improve the functionalities its Apple Watch. She also believes that Apple has been able to avoid taking accountability for this by “bombarding” smaller companies with litigation it knows they won’t be able to afford — a claim that medical IP lawyers have backed up.

Medical 130
article thumbnail

Early Career Professionals in Scholarly Publishing Tell All

Copyright Clearance Center

The post Early Career Professionals in Scholarly Publishing Tell All appeared first on Copyright Clearance Center.

79
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Insurer “Delay and Deny” Practices Continue to Threaten Patients’ Timely Access to Gastrointestinal Care – It’s Time for Reform

MedCity News

Insurers should immediately end their overreach into medical decision-making and work with medical providers and their patients to ensure timely care for all.

Insurance 110
article thumbnail

Navigating Paxlovid Interactions With Anticoagulants

Pharmacy Times

Interactions between nirmatrelvir/ritonavir and direct oral anticoagulants is complicated, and a point of contrasting views between the US and EU medical communities.

Medical 40
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Akebia Recovers From Rejection to Win FDA Approval for Anemia Drug

MedCity News

Approval of Akebia Therapeutics’ Vafseo is based on additional post-marketing safety data from Japan, where the drug has been used since 2020. The FDA rejected the drug two years ago due to concerns about cardiovascular safety.

FDA 102
article thumbnail

4 Funding Announcements Made By Payer/Employer Health Tech Startups in March

MedCity News

Here is a list of some of the biggest funding rounds in the payer/employer space that were announced this month.

102
102